Headquarters
THIRD FLOOR 23 OLD BOND STREET, LONDON W1S 4PZ, GB
LONDON, GB
KINIKSA PHARMACEUTICALS (UK), LTD.
From the company
Kiniksa Pharmaceuticals is a global biopharmaceutical company founded in 2015 that finds and delivers novel treatments for patients with significant unmet need, with a focus on cardiovascular diseases and immune modulation. Its portfolio includes an FDA-approved therapy and clinical-stage assets, including KPL-387, an investigational monoclonal antibody IL-1 receptor antagonist being evaluated in the Phase 3 PASTORALE trial in recurrent pericarditis.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.